Last but not least, shares of NPS Pharmaceuticals are up more than 18% in pre-market trading in anticipation of a bid from Shire.
Shire recently lined up a $5 billion credit facility from several banks led by Citigroup to finance its takeover offer for NPS. The Times reported that NPS board...
Monday"s Top Biotech Stories: Ariad, Omeros, NPS Pharmaceuticals, and Shire
Monday, June 2, 2014
Monday"s Top Biotech Stories: Ariad, Omeros, NPS Pharmaceuticals, and Shire
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment